Insiders / Dandekar Atul / Activity
Activity — Dandekar Atul
11 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jan 29, 2026 | Sell | MAZE Maze Therapeutics, Inc. Common Stock | $51.8K | -1K -6.67% | 16,803 0.03% of shares | low |
| Feb 27, 2026 | Exercise | MAZE Maze Therapeutics, Inc. Common Stock | $78.2K | +8K +71.41% | 18,003 0.03% of shares | low |
| Jan 29, 2026 | Exercise | MAZE Maze Therapeutics, Inc. Common Stock | $78.2K | +8K +71.41% | 18,003 0.03% of shares | low |
| Jan 29, 2026 | Sell | MAZE Maze Therapeutics, Inc. Common Stock | $126.0K | -3K -21.05% | 10,503 0.02% of shares | medium |
| Jan 29, 2026 | Sell | MAZE Maze Therapeutics, Inc. Common Stock | $154.1K | -4K -20.83% | 13,303 0.02% of shares | medium |
| Feb 27, 2026 | Sell | MAZE Maze Therapeutics, Inc. Common Stock | $168.8K | -4K -20.77% | 14,264 0.03% of shares | medium |
| Feb 27, 2026 | Sell | MAZE Maze Therapeutics, Inc. Common Stock | $172.0K | -4K -26.37% | 10,503 0.02% of shares | medium |
| Mar 2, 2026 | Grant | MAZE Maze Therapeutics, Inc. Restricted Stock Units | — | +19K | 19,000 0.03% of shares | low |
| Mar 2, 2026 | Grant | MAZE Maze Therapeutics, Inc. Stock Option (Right to Buy) | — | +38K | 38,000 0.07% of shares | low |
| Feb 27, 2026 | Exercise | MAZE Maze Therapeutics, Inc. Stock Option (Right to Buy) | — | -8K -11.25% | 59,143 0.11% of shares | low |
| Jan 29, 2026 | Exercise | MAZE Maze Therapeutics, Inc. Stock Option (Right to Buy) | — | -8K -10.12% | 66,643 0.12% of shares | low |